Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3VIIV HLTHCARE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

Brand Name : CABENUVA KIT

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML)

Approval Date : 2021-01-21

Application Number : 212888

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

CABOTEGRAVIR; RILPIVIRINE

Brand Name : CABENUVA KIT

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML)

Approval Date : 2021-01-21

Application Number : 212888

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

CABOTEGRAVIR

Brand Name : APRETUDE

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 600MG/3ML (200MG/ML)

Approval Date : 2021-12-20

Application Number : 215499

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank